Breast Cancer Clinical Trials

A listing of Breast Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Languages supported at study center
Age Group

Female only (54)
Any (49)

Phase 1 (13)
Phase 1/2 (6)
Phase 2 (13)
Phase 2/3 (1)
Phase 3 (6)
Phase 4 (1)
Unknown (62)

Interventional (70)
Observational (30)

Fudan University (5)
Dana-Farber Cancer Institute (3)
Samsung Medical Center (3)
British Columbia Cancer Agency (2)
Institut du Cancer de Montpellier - Val d'Aurelle (2)
SOLTI Breast Cancer Research Group (2)
Sanofi (2)
Shenzhen Geno-Immune Medical Institute (2)
Sunnybrook Health Sciences Centre (2)
Weill Medical College of Cornell University (2)
Alexandria University (1)
Assistance Publique - Hôpitaux de Paris (1)
Atreca, Inc. (1)
Azienda Unità Sanitaria Locale Reggio Emilia (1)
Baylor Research Institute (1)
BeiGene (1)
Beta Pharma (Suzhou) Co., Ltd. (1)
Bolt Biotherapeutics, Inc. (1)
Bulent Ecevit University (1)
Cankado Service GmbH (1)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)
Chinese Academy of Medical Sciences (1)
City of Hope Medical Center (1)
Columbia University (1)
Dartmouth-Hitchcock Medical Center (1)
Dr. Tabassum Wadasadawala (1)
Erasme University Hospital (1)
European Breast Cancer Reseach Association of Surgical Trialists (1)
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1)
Fox Chase Cancer Center (1)
Gencurix, Inc. (1)
Guardant Health, Inc. (1)
H. Lee Moffitt Cancer Center and Research Institute (1)
H3 Biomedicine Inc. (1)
Hellenic Society of Medical Oncology (1)
Herui Yao (1)
Institut Cancerologie de l'Ouest (1)
Institut Curie (1)
Institut Jean-Godinot (1)
Jiangxi Provincial Cancer Hospital (1)
Jilin University (1)
King Hussein Cancer Center (1)
Kliniken Essen-Mitte (1)
Maastricht University Medical Center (1)
Mansoura University (1)
Masonic Cancer Center, University of Minnesota (1)
Mayo Clinic (1)
Memorial Sloan Kettering Cancer Center (1)
NBE-Therapeutics AG (1)
National Cancer Institute (NCI) (1)
Northwestern University (1)
Novartis Pharmaceuticals (1)
Peking Union Medical College Hospital (1)
Peking University (1)
Pierre Fabre Pharma GmbH (1)
PureTech (1)
Rebecca Kaltman, MD (1)
Seattle Genetics, Inc. (1)
Second Affiliated Hospital, School of Medicine, Zhejiang University (1)
Shanghai Jiao Tong University School of Medicine (1)
Shanghai Pharmaceuticals Holding Co., Ltd (1)
Shayna Showalter, MD (1)
St. Justine's Hospital (1)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)
Swiss Group for Clinical Cancer Research (1)
Syros Pharmaceuticals (1)
Tactile Medical (1)
Taipei Medical University (1)
Texas Tech University Health Sciences Center, El Paso (1)
The Affiliated Hospital of Qingdao University (1)
The First Affiliated Hospital of Dalian Medical University (1)
The First Affiliated Hospital of the Fourth Military Medical University (1)
The Second Affiliated Hospital of Harbin Medical University (1)
Thurgau Breast Center (1)
Turku University Hospital (1)
UMC Utrecht (1)
UNICANCER (1)
University Hospital, Basel, Switzerland (1)
University Medical Center Groningen (1)
University of British Columbia (1)
University of California, San Diego (1)
University of Massachusetts, Amherst (1)
Virginia Commonwealth University (1)
Zealand University Hospital (1)
Zhejiang Cancer Hospital (1)
pfizer (1)

No (91)
Yes (12)

No (103)

English (1)

Adult (18+) (103)
Pediatric (Under 18) (9)

I am/have/had

I am/have/hadbreast cancer

I am/have/hadcancer

I am/have/hadstage iv breast cancer

I am/have/hadsentinel node

I am/have/hadmastectomy

I am/have/haderbb2

I am/have/hadestrogen

I am/have/hadinvasive breast cancer

I am/have/hadlumpectomy

I am/have/hadmetastasis

I am/have/hadadenocarcinoma of the breast

I am/have/hadmeasurable disease

I am/have/hadbreast carcinoma

I am/have/hadaxillary lymph node dissection

I am/have/hadadvanced breast cancer

I am/have/hadestrogen receptor

I am/have/hadbreast cancer staging

I am/have/hadbreast-conserving surgery

I am/have/hadadjuvant chemotherapy

I am/have/hadbreast surgery

added new label for I am/have/had

I am looking for

I am looking forimmunostimulant

I am looking forhormone therapy

I am looking forendocrine therapy

I am looking fortrastuzumab

I am looking forerbb2

I am looking forestrogen

I am looking fortamoxifen

I am looking foraromatase inhibitor

I am looking forpaclitaxel

I am looking fortaxane

I am looking forherceptin

I am looking forletrozole

I am looking forepirubicin

I am looking fordocetaxel

I am looking foranthracyclines

I am looking foranastrozole

I am looking forcyclophosphamide

I am looking forprogesterone

I am looking fordoxorubicin

I am looking forepidermal growth factor

added new label for I am looking for

Advanced Filters

Found 5361 clinical trials

For Seniors
For adults
Recruiting in 100s
Interventional Study
For Females
Cardiovascular Diseases
Recruiting

Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer

Comparing preventive effect of myocardial global longitudinal strain-based cardioprotective stragety (angiotensin receptor blocker prophylaxis) with left ventricular ejection fraction-based strategy in breast cancer patients treated with adjuvant trastuzumab.

her2-positive breast cancer

breast cancer

her2+ breast cancer

cardiotoxicity

adjuvant

0 views
19 Feb, 2024
1 location

For Seniors
For adults
Recruiting in 10s
Interventional Study
For Females
Recruiting

Cryoablation Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer

This early phase I trial studies the side effects and feasibility of cryoablation, atezolizumab, and nab-paclitaxel in treating patients with triple negative breast cancer that has spread to nearby tissue or lymph nodes (locally advanced) or has spread to other places in the body (metastatic). Cryosurgery, also known as cryoablation …

locally advanced breast carcinoma

breast tumor

breast cancer

monoclonal antibodies

progesterone

0 views
19 Feb, 2024
1 location

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Cardiovascular Diseases
Recruiting

Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy

This study will evaluate the efficacy and safety of antharcycline-based adjuvant chemotherapy compared with observation in triple negative breast cancer (TNBC) patients with residual invasive disease after platinum and taxanes based neoadjuvant chemotherapy.

breast cancer

tumor excision

adjuvant

breast surgery

renal disease

0 views
19 Feb, 2024
1 location

For Seniors
For adults
Recruiting in 100s
Interventional Study
For Females
Recruiting

A Patient-centered Continuous and Interdisciplinary Shared Decision Making Approach for Breast Cancer Rehabilitation

Background: Breast cancer rehabilitation has gradually expanded from post-surgery rehabilitation to continuous rehabilitation including prehabilitation between cancer diagnosis and surgical treatment, post-surgery rehabilitation, and return-to-work/return-home interventions.

0 views
19 Feb, 2024
1 location

For Seniors
For adults
Recruiting in 100s
Interventional Study
For Females
Family Medicine
Recruiting

Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer

Interventional, randomised, prospective, monocentric study

narcotic drugs

breast cancer

adjuvant

homeopathic

metastatic breast cancer

0 views
19 Feb, 2024
1 location

Phase 1
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast Cancer

The purpose of this study is to evaluate the safety, efficacy and pharmacokinetics of BPI-1178 in subjects with advanced solid tumor, as well as the subjects with advanced hormone receptor-positive(HR+)/human epidermal growth factor receptor 2 negative (HER2-) breast cancer.

letrozole

breast cancer

her2- breast cancer

solid tumor

adjuvant

0 views
19 Feb, 2024
1 location

For Seniors
For adults
Recruiting in 10s
Interventional Study
For Females
Endocrinology
Recruiting

Remotivation Process for Improving Adherence to Lymphedema Treatment Programs in Patients With Breast Cancer-Related Lymphedema

This trial studies how well the Remotivation Process in an occupational therapy program works in improving adherence to lymphedema treatment programs in patients with breast cancer-related lymphedema. Lymphedema treatment programs are well developed and effective, but adherence to these programs are an issue.

breast cancer

carcinoma

lymphedema

cancer

breast carcinoma

0 views
19 Feb, 2024
1 location

Phase 3
For Seniors
For adults
Recruiting in 100s
Interventional Study
For Females
Cardiovascular Diseases
Recruiting

Evaluating the Clinical Value of Traditional Chinese Medicine in the Adjuvant Therapy of Triple-negative Breast Cancer

This is a prospective, single site, randomized, double-blind Phase III clinical trial to evaluate the clinical value of Traditional Chinese Medicine in the adjuvant therapy of triple-negative breast cancer patients.

breast cancer

progesterone

adjuvant

traditional chinese medicine

creatinine clearance rate

0 views
19 Feb, 2024
1 location

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Endocrinology
Recruiting

LYT-100 in Healthy Volunteers and BCRL

Part 3 is a trial of up to 6-months duration for safety, tolerability, PK, biomarkers and exploratory clinical assessments in breast carcinoma patients with secondary lymphoedema

nipple reconstruction

breast cancer

lymphedema

metastasis

adjuvant

0 views
19 Feb, 2024
1 location

Multi-country trial
Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Females
Family Medicine
Recruiting

A Study of H3B-6545 in Combination With Palbociclib in Women With Advanced or Metastatic Estrogen Receptor-Positive Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer

The primary objective of this study is to evaluate the safety and tolerability of H3B-6545 and palbociclib when administered in combination in order to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of this combination in women with advanced or metastatic estrogen receptor-positive (ER+) HER2- …

breast cancer

her2- breast cancer

growth factor

stage iv breast cancer

estrogen receptor

0 views
19 Feb, 2024
7 locations